These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1649388)

  • 21. Identification of MRF4, myogenin, and E12 oligomer complexes by chemical cross-linking and two-dimensional gel electrophoresis.
    Lin H; Konieczny SF
    J Biol Chem; 1992 Mar; 267(7):4773-80. PubMed ID: 1311321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The four human muscle regulatory helix-loop-helix proteins Myf3-Myf6 exhibit similar hetero-dimerization and DNA binding properties.
    Braun T; Arnold HH
    Nucleic Acids Res; 1991 Oct; 19(20):5645-51. PubMed ID: 1945842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the oligomerization of myogenin and E2A products in vivo using a two-hybrid assay system.
    Chakraborty T; Martin JF; Olson EN
    J Biol Chem; 1992 Sep; 267(25):17498-501. PubMed ID: 1325437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Muscle-specific expression of the troponin I gene requires interactions between helix-loop-helix muscle regulatory factors and ubiquitous transcription factors.
    Lin H; Yutzey KE; Konieczny SF
    Mol Cell Biol; 1991 Jan; 11(1):267-80. PubMed ID: 1846022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Domains outside of the DNA-binding domain impart target gene specificity to myogenin and MRF4.
    Chakraborty T; Olson EN
    Mol Cell Biol; 1991 Dec; 11(12):6103-8. PubMed ID: 1658626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo.
    Lassar AB; Davis RL; Wright WE; Kadesch T; Murre C; Voronova A; Baltimore D; Weintraub H
    Cell; 1991 Jul; 66(2):305-15. PubMed ID: 1649701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
    Spinner DS; Liu S; Wang SW; Schmidt J
    J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties.
    Santoro IM; Walsh K
    Mol Cell Biol; 1991 Dec; 11(12):6296-305. PubMed ID: 1658630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site.
    Spitz F; Demignon J; Porteu A; Kahn A; Concordet JP; Daegelen D; Maire P
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14220-5. PubMed ID: 9826681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the 5'-flanking region of the gene for the alpha chain of human fibrinogen.
    Hu CH; Harris JE; Davie EW; Chung DW
    J Biol Chem; 1995 Nov; 270(47):28342-9. PubMed ID: 7499335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the human p11 promoter sequence.
    Huang X; Pawliczak R; Yao XL; Madara P; Alsaaty S; Shelhamer JH; Cowan MJ
    Gene; 2003 May; 310():133-42. PubMed ID: 12801640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL6 encodes a sequence-specific DNA-binding protein.
    Baron BW; Stanger RR; Hume E; Sadhu A; Mick R; Kerckaert JP; Deweindt C; Bastard C; Nucifora G; Zeleznik-Le N
    Genes Chromosomes Cancer; 1995 Jul; 13(3):221-4. PubMed ID: 7669744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A developmental and tissue-specific enhancer in the mouse skeletal muscle acetylcholine receptor alpha-subunit gene regulated by myogenic factors.
    Prody CA; Merlie JP
    J Biol Chem; 1991 Nov; 266(33):22588-96. PubMed ID: 1658001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers.
    Sun XH; Baltimore D
    Cell; 1991 Jan; 64(2):459-70. PubMed ID: 1846322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple binding sites for myogenic regulatory factors are required for expression of the acetylcholine receptor gamma-subunit gene.
    Gilmour BP; Fanger GR; Newton C; Evans SM; Gardner PD
    J Biol Chem; 1991 Oct; 266(30):19871-4. PubMed ID: 1657903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
    Wright WE; Dac-Korytko I; Farmer K
    Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The regulation of myogenin gene expression during the embryonic development of the mouse.
    Yee SP; Rigby PW
    Genes Dev; 1993 Jul; 7(7A):1277-89. PubMed ID: 8391506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physical interaction between the mitogen-responsive serum response factor and myogenic basic-helix-loop-helix proteins.
    Groisman R; Masutani H; Leibovitch MP; Robin P; Soudant I; Trouche D; Harel-Bellan A
    J Biol Chem; 1996 Mar; 271(9):5258-64. PubMed ID: 8617811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transactivation of capn2 by myogenic regulatory factors during myogenesis.
    Dedieu S; Mazères G; Dourdin N; Cottin P; Brustis JJ
    J Mol Biol; 2003 Feb; 326(2):453-65. PubMed ID: 12559913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the RUSH consensus-binding site by cyclic amplification and selection of targets: demonstration that RUSH mediates the ability of prolactin to augment progesterone-dependent gene expression.
    Hewetson A; Hendrix EC; Mansharamani M; Lee VH; Chilton BS
    Mol Endocrinol; 2002 Sep; 16(9):2101-12. PubMed ID: 12198246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.